openPR Logo
Press release

Clostridium Vaccine Market 2018-2026 | Top Key Venders: Valneva SE and Pfizer, Inc

04-01-2019 03:50 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Clostridium Vaccine

Clostridium Vaccine

Rising incidence and high prevalence of clostridium difficile infection is expected to boost growth of the market over the forecast period. Incidence of clostridium difficile infection has been witnessing an increase since the recent past, due to its infection recurrence and antibiotic resistance. According to Centers for Disease Control and Prevention (CDC), in 2015 around half a million people in the U.S. suffer from clostridium difficile infection in a year.

Get PDF Sample Copy of this Report @ http://bit.ly/2JSm0gj

Moreover, according to National Center for Biotechnology Information (NCBI), an estimated 37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review and meta-analysis of studies published in National Center for Biotechnology Information (NCBI), 2016, conducted in China between 2010 and 2016, reported significant incidence of clostridium difficile infection in China.

Currently, there is no alternative therapies apart from antibiotics available for the treatment of clostridium difficile infection and only option available is surgery (in severe cases), fecal microbiota transplant, and probiotics in case of recurrent clostridium difficile infection.

Moreover, key pharmaceutical players are engaged in conducting clinical trials for development of clostridium vaccine that can offer preventive measure in the clostridium difficile infection in near future.

For instance, in January 2017; Pfizer announced phase II study of investigational clostridium difficile vaccine candidate: PF-06425090; for the prevention of C. difficile infection. This randomized phase II study was conducted to examine the safety, tolerability, and immunogenicity of the vaccine in healthy adults 65 to 85 years of age. Pfizer initiated a phase III study in March 2017, with around 16,000 participants.

In July 2016, Valneva SE announced the successful completion of its phase II clinical study for its prophylactic vaccine candidate VLA84 targeting on primary prevention of C. difficile infection (CDI).

Key players operating in global clostridium vaccine market include Valneva SE and Pfizer, Inc.

Inquire about Discount on this Report @ http://bit.ly/2JWrwi3

Growing C. difficile infections at healthcare facilities and antibiotic resistance to treatment drugs are propelling demand for development of prophylactic options to reduce the risk of infection in vulnerable patients. A 2013 bulletin published from the Centers for Disease Control and Prevention (CDC) outlined Clostridium difficile as urgent antibiotic-resistance threats in the U.S

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clostridium Vaccine Market 2018-2026 | Top Key Venders: Valneva SE and Pfizer, Inc here

News-ID: 1681736 • Views: 363

More Releases from Coherent Market Insights

Angioedema Treatment Market Anlysis with Inputs form Industry with top key playe …
"Coherent Market Insights" added the 2026 Angioedema Treatment Market Report, which describes current and future growth trends for this activity, as well as describing the details of the myriad of regions within the regional market landscape. The report presents important information on the size of the market, market share, regional trends and profit projections of this sphere of activity. Reasons to invest in this report: • Develop / modify small business development
Operating Room Equipment & Supplies Market Register a Hugh Growth In Healthcare …
"Coherent Market Insights" added the 2026 Pharmaceutical Robots Market Report, which describes current and future growth trends for this activity, as well as describing the details of the myriad of regions within the regional market landscape. The report presents important information on the size of the market, market share, regional trends and profit projections of this sphere of activity. Reasons to invest in this report: • Develop / modify small business development
Pharmaceutical Robots Market Competitive Scenario & Market Dynamics with top key …
Laboratory robotics is an act of using robots in life science, chemistry, and pharmaceutical laboratories to perform tasks which are beyond human capabilities such as continuous productivity and safety. Laboratory automation is the prominent segment in robotics field. Robots can perform task three to four times faster than humans and can work up to 24 hours a day. They can produce large quantity of products such as pharmaceutical drugs in
Global Atherectomy Devices Market Opportunities, Drivers, Challenges with top ke …
"Coherent Market Insights" added the 2026 atherectomy Devices Market Report, which describes current and future growth trends for this activity, as well as describing the details of the myriad of regions within the regional market landscape. The report presents important information on the size of the market, market share, regional trends and profit projections of this sphere of activity. Reasons to invest in this report: • Develop / modify small business development

All 5 Releases


More Releases for Clostridium

Clostridium Vaccine Market to Witness Robust Expansion by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Clostridium Vaccine market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/212021/global-clostridium-vaccine-market Global Clostridium Vaccine Market: Forecast by Type / Application / Region According to this study, over the next five years the Clostridium Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of
Collagenase Clostridium Histolyticum Market Trends, Analysis and Forecast 2016 - …
Global Collagenase Clostridium Histolyticum Market: Overview Collagenase clostridium histolyticum is primarily used in the treatment of Dupuytren’s contracture and Peyronie’s disease. Thus, the global market for collagenase clostridium histolyticum is gaining traction due to the rising prevalence of these two diseases, especially in developed countries. Request Brochure- https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4474 Collagenase is an enzyme that helps in breaking down the chord of thickened tissue and permits straightening of fingers. Some of the primary medications available in
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of
Clostridium Vaccine Market : Share, Analysis To 2024
The global clostridium vaccine (animal health) market features a largely consolidated competitive landscape, with the top five companies collectively accounting for a share of over 63% of the overall market in 2015, observes a recent report by Transparency Market Research (TMR). These top vendors, namely Zoetis, Inc., Merck & Co., Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly and Company hold commanding positions owing to their wide geographic presence and a strong
Clostridium Vaccine Market to Grow Exponentially
Global Clostridium Vaccines Market: Snapshot Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and tetanus. The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases. Rising concerns about the mortality of livestock animal and the socioeconomic impact of it on agrarian economies are